Rosalind Advisors »

Viking Therapeutics Inc call shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Viking Therapeutics Inc call shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Viking Therapeutics Inc call

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics Inc call held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics Inc call by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0k 100k 0.02

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Savara (SVRA)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Miragen Therapeutics (VRDN)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Replimune Group (REPL)
Atyr Pharma (ATYR)
Cybin Com New (HELP)
Eyepoint Pharmaceuticals Com New (EYPT)
Cg Oncology (CGON)
Cytokinetics Com New (CYTK)
X4 Pharmaceuticals Com New (XFOR)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Viking Therapeutics Inc call

Group One Trading
Simplex Trading
IMC-Chicago
Rosalind Advisors
Jpmorgan Chase & Co
Sender Co & Partners
Procyon Private Wealth Partners
Persistent Asset Partners

View all funds holding Viking Therapeutics Inc call